Onward Med Nv (ONWRF) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Onward Medical N.v..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.997 Welcome everyone to Onward's webcast. Earlier today, we shared our results for the first 00:00:04.997 -- 00:00:06.779 quarter of 2025 00:00:06.779 -- 00:00:11.064 and year-to-date highlights via a press release available on our site. 00:00:11.064 -- 00:00:15.970 The replay of this webcast will also be made available on our investor relations platform 00:00:15.970 -- 00:00:21.377 after the session. Before we get started, please take a moment to read this page. 00:00:21.377 -- 00:00:25.963 Today's presentation includes four looking statements, which should be considered with 00:00:25.963 -- 00:00:31.247 the appropriate level of caution as outlined in the disclaimer. 00:00:33.410 -- 00:00:39.421 Today I'm joined by Dave Marver, CEO, and Amaury Fraser, Senior Finance Director. 00:00:39.421 -- 00:00:44.711 Dave and Amaury will provide an update on our progress before we open for questions. 00:00:44.711 -- 00:00:49.701 You may submit your questions verbally or via the Q&A module on the platform. 00:00:49.701 -- 00:00:53.761 With that, I'll hand over to Dave. Thank you. 00:00:53.761 -- 00:00:59.109 thank you sharon thank you sev thank you to all of you who are joining us today 00:00:59.109 -- 00:01:04.137 as is our tradition i like to start with a company overview for those of 00:01:04.137 -- 00:01:06.881 you who are new to the story 00:01:06.881 -- 00:01:11.929 onward is pioneering therapies to restore movement function and independence in people 00:01:11.929 -- 00:01:17.057 with spinal cord injury and other movement disabilities we are doing so 00:01:17.057 -- 00:01:22.419 with three persistent neuromodulation platforms ARC-EX, 00:01:22.419 -- 00:01:25.701 ARC-IM, and ARC-BCI. 00:01:25.724 -- 00:01:29.590 ARC-EX delivers ARC therapy ext...